Texas biotech ex­pands R&D and man­u­fac­tur­ing ca­pa­bil­i­ties fol­low­ing Catal­ent part­ner­ship

On­ly months af­ter Texas-based TFF Phar­ma­ceu­ti­cals net­ted a part­ner­ship with Catal­ent, the com­pa­ny is ex­pand­ing its R&D and man­u­fac­tur­ing op­er­a­tions in the cap­i­tal of the Lone Star State, through the lease of a new 3,500-square-foot fa­cil­i­ty.

The new space will be cen­tered on in­creas­ing TFF’s to­tal lab space. The ex­pan­sion adds a ded­i­cat­ed lab for the down­stream pro­cess­ing of prod­ucts cre­at­ed via its thin film freez­ing as the com­pa­ny is look­ing to in­crease its in-house re­search. The ad­di­tion­al lab space will al­low the com­pa­ny to house larg­er equip­ment to scale up its man­u­fac­tur­ing abil­i­ties and pro­duce sup­plies for pre­clin­i­cal stud­ies. TFF plans to take its new space on­line by Au­gust.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER